Rising applied sciences in healthcare, half 5: Augmedics

Rising applied sciences in healthcare, half 5: Augmedics

Editor’s note: While Nissan Elimelech founded Augmedics and invented its foundational technology, he is no longer affiliated with or represents the company. In 2014, Nissan Elimelech founded Augmedics, the company behind an augmented reality surgical navigation platform for spine procedures. He is credited with developing the xvision Spine System, which uses a transparent near-eye display … Read more

Rising applied sciences in healthcare, half 4: MedTech Innovator

Rising applied sciences in healthcare, half 4: MedTech Innovator

MedTech Innovator is an accelerator that works with large companies to invest in, support and scale healthcare technology companies. Its partners include Johnson & Johnson, the American Heart Association, and others. MedTech has graduated more than 700 companies with 93% of them still in business.  Paul Grand, CEO of MedTech Innovator, spoke with MobiHealthNews about … Read more

Rising applied sciences in healthcare, half 3: Lila Sciences

Rising applied sciences in healthcare, half 3: Lila Sciences

Lila Sciences is developing an AI-enabled scientific superintelligence platform—paired with autonomous labs—that can run the entire scientific method. In a conversation with MobiHealthNews, Molly Gibson, president of future science at Lila Sciences, explained that this technology extends beyond traditional AI applications, such as protein modeling, by generating hypotheses, designing experiments and learning from results. She … Read more

Rising applied sciences in healthcare, half 2: Common Catalyst

Rising applied sciences in healthcare, half 2: Common Catalyst

U.S.-based General Catalyst is one of the largest venture capital firms globally, with a diverse portfolio of companies across various industries, including healthcare. Alexandre Momeni, a partner at General Catalyst focusing on AI infrastructure and health/bio, sat down with MobiHealthNews to discuss the investor’s perspective on funding emerging technologies, the risks associated with these investments and … Read more